Alliance for Clinical Trials in Oncology: Leukemia trials

The registry lists 37 Leukemia studies with Alliance for Clinical Trials in Oncology as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 2Phase 2 17Phase 3 5No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01027000Phase 2Results posted
• American Ginseng in Treating Patients With Fatigue Caused by CancerCompletedNCT00719563Phase 3Results posted
• Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00651261Phase 3Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00558519Phase 2Results posted
• Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaTerminatedNCT00513747Phase 3Results posted
• Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete RemissionCompletedNCT00070135Phase 2Results posted
• Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's LeukemiaCompletedNCT00039130Phase 2Results posted
• Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple MyelomaCompletedNCT03870633
• Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic LeukemiaCompletedNCT01284010
• Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT01005368
• Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720CompletedNCT01004965
• Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical TrialActive, not recruitingNCT01004640
• Studying Tissue and Blood Samples From Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00900224
• Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic SyndromesActive, not recruitingNCT00899223
• Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00898456
• Genetics Study of Tissue Collected From Patients With Acute Myeloid LeukemiaStatus unknownNCT00898092
• Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid LeukemiaCompletedNCT00897182
• Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2CompletedNCT00896701
• Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
• Cytogenetic Studies in Acute Leukemia and Multiple MyelomaActive, not recruitingNCT00048958
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerCompletedNCT00031980Phase 2
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
• Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00006265Phase 2
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaCompletedNCT00005829Phase 2
• Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon AlfaTerminatedNCT00004933Phase 3
• Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00004857Phase 2
• 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentTerminatedNCT00004239Phase 1
• Diagnostic Study of Gene Alterations in Patients With Acute Myeloid LeukemiaCompletedNCT00003931
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic LeukemiaActive, not recruitingNCT00003861
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00003255Phase 2
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionCompletedNCT00002768Phase 2
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00002494Phase 2